Rapid communications in mass spectrometry : RCM · 2026
LC-HRMS/MS Characterization of Hydrolytic and Photolytic Degradation Pathways of Ripretinib Following Forced Stress Studies.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Golla Vijaya Madhyanapu, Pilli Pushpa, Kushwah Bhoopendra Singh, Chaganti Sowmya, Khemchandani Rahul, Samanthula Gananadhamu
Аннотация
INTRODUCTION: Ripretinib is an innovative multitargeted kinase inhibitor introduced for the treatment of advanced gastrointestinal stromal tumors, was investigated to elucidate its degradation behavior and structural transformation pathways under forced stress conditions. Although degradation studies are essential for evaluating the intrinsic stability of pharmaceutical compounds, the degradation products of ripretinib have not been comprehensively characterized. The present work focuses on LC-HRMS/MS-based structural elucidation of degradation products arising from photolytic and hydrolytic stress conditions.
METHODS: In accordance with International Council for Harmonisation guidelines, ripretinib was subjected to acidic, alkaline, oxidative, thermal, and photolytic stress conditions. Liquid chromatography was employed to separate the degradation products, which were subsequently characterized by high-resolution tandem mass spectrometry (LC-HRMS/MS) operated in positive electrospray ionization mode. Structural assignments were established using accurate mass measurements, isotopic pattern analysis, elemental composition determination, and collision-induced dissociation pathways. Degradation kinetics under photolytic conditions were also evaluated. An in silico toxicity assessment of degradation products was performed using DEREK and SARAH prediction platforms.
RESULTS: Ripretinib exhibited degradation predominantly under photolytic and hydrolytic stress conditions, leading to the formation of five degradation products. The protonated molecule of ripretinib at m/z 510 displayed a characteristic bromine isotopic distribution that facilitated differentiation between brominated and debrominated products. Hydrolytic degradation generated two products through cleavage of the urea linkage, whereas photolytic degradation produced three products involving intramolecular cyclization with concomitant debromination, hydroxylation, and N-C bond cleavage pathways. Collision-induced dissociation of protonated molecules generated diagnostic product ions that enabled structural elucidation of all degradation products. Photodegradation followed apparent first-order kinetics with a half-life of 4.2 min. One hydrolytic degradation product containing a primary aromatic amine moiety was predicted to possess mutagenic potential.
CONCLUSION: This investigation elucidates the degradation pathways of ripretinib and highlights the utility of LC-HRMS/MS in the structural characterization of degradation products generated under stress conditions.
METHODS: In accordance with International Council for Harmonisation guidelines, ripretinib was subjected to acidic, alkaline, oxidative, thermal, and photolytic stress conditions. Liquid chromatography was employed to separate the degradation products, which were subsequently characterized by high-resolution tandem mass spectrometry (LC-HRMS/MS) operated in positive electrospray ionization mode. Structural assignments were established using accurate mass measurements, isotopic pattern analysis, elemental composition determination, and collision-induced dissociation pathways. Degradation kinetics under photolytic conditions were also evaluated. An in silico toxicity assessment of degradation products was performed using DEREK and SARAH prediction platforms.
RESULTS: Ripretinib exhibited degradation predominantly under photolytic and hydrolytic stress conditions, leading to the formation of five degradation products. The protonated molecule of ripretinib at m/z 510 displayed a characteristic bromine isotopic distribution that facilitated differentiation between brominated and debrominated products. Hydrolytic degradation generated two products through cleavage of the urea linkage, whereas photolytic degradation produced three products involving intramolecular cyclization with concomitant debromination, hydroxylation, and N-C bond cleavage pathways. Collision-induced dissociation of protonated molecules generated diagnostic product ions that enabled structural elucidation of all degradation products. Photodegradation followed apparent first-order kinetics with a half-life of 4.2 min. One hydrolytic degradation product containing a primary aromatic amine moiety was predicted to possess mutagenic potential.
CONCLUSION: This investigation elucidates the degradation pathways of ripretinib and highlights the utility of LC-HRMS/MS in the structural characterization of degradation products generated under stress conditions.